Robert Olstein recent buys & sells (2025 Q2)
Olstein Capital Management
Olstein Capital Management Portfolio Changes
Purchase & sale details
- Portfolio value:
- $533.44M (-$10M)
- Previous value:
- $543.23M
- # of changes:
- 89
- New positions:
- 4
- Reported for:
- 30 Jun 2025 (Q2)
- Latest filing date:
- 22 Jul 2025
Olstein Capital Management has disclosed a total of 89 changes to the portfolio in the (2025 Q2) SEC report(s): increased the number of shares of 37, bought 4 totally new, decreased the number of shares of 47 and completely sold out 1 position(s).
What stocks did Robert Olstein buy in 2025 Q2?
During 2025 Q2 Robert Olstein has bought 41 securities out of which top 5 purchases (by % change to portfolio) were (VNT) Vontier Corp (added shares +1.03%), (ABM) ABM Industries Incorporated (added shares +8.15%), (AVTR) Avantor Inc (added shares +19.54%), (BDX) Becton Dickinson and Company (added shares +18.60%) and (SLB) Schlumberger NV (added shares +0.40%).
In the 2025 Q2 report(s) the following changes have been made to the top investments: (DIS) Walt Disney Company (reduced shares -19.71%), (ST) Sensata Technologies Holding NV (reduced shares -17.71%), (VNT) Vontier Corp (added shares +1.03%) and (ABM) ABM Industries Incorporated (added shares +8.15%).
89 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Adobe Inc
|
new
|
+10,000
|
10,000
|
+0.73%
|
$386.90
|
-35.92%($247.94)
|
0.73%
|
2025 Q2
|
~0.25 years
|
|
|
|
NOV Inc
|
new
|
+42,000
|
42,000
|
+0.1%
|
$12.43
|
+56.78%($19.48)
|
0.10%
|
2025 Q2
|
~0.25 years
|
|
|
|
Ralliant Corp
|
new
|
+27,166
|
27,166
|
+0.25%
|
$48.48
|
+42.60%($69.13)
|
0.25%
|
2025 Q2
|
~0.25 years
|
|
|
|
Thermo Fisher Scientific Inc
|
new
|
+8,000
|
8,000
|
+0.61%
|
$405.50
|
+73.54%($703.68)
|
0.61%
|
2025 Q2
|
~0.25 years
|
|
|
|
Chubb Ltd
|
+88.89%
|
+8,000
|
17,000
|
+0.43%
|
$289.71
|
+23.66%($358.25)
|
0.92%
|
2025 Q1
|
~0.50 years
|
|
|
|
UnitedHealth Group Incorporated
|
+78.57%
|
+11,000
|
25,000
|
+0.64%
|
$311.96
|
+31.38%($409.86)
|
1.46%
|
2014 Q1
|
~11.50 years
|
|
|
|
Fiserv, Inc
|
+65.79%
|
+12,500
|
31,500
|
+0.4%
|
$172.41
|
-72.49%($47.43)
|
1.02%
|
2024 Q2
|
~1.25 years
|
|
|
|
Integra LifeSciences Holdings
|
+37.76%
|
+37,000
|
135,000
|
+0.09%
|
$12.27
|
+0.11%($12.28)
|
0.31%
|
2019 Q2
|
~6.25 years
|
|
|
|
PepsiCo Inc
|
+33.33%
|
+7,000
|
28,000
|
+0.17%
|
$132.04
|
+0.52%($132.72)
|
0.69%
|
2025 Q1
|
~0.50 years
|
|
|
|
Jones Lang LaSalle Incorporated
|
+25.28%
|
+5,650
|
28,000
|
+0.27%
|
$255.79
|
+31.68%($336.81)
|
1.34%
|
2021 Q1
|
~4.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".